MDXG MIMEDX GROUP, INC.
Nasdaq · SEC CIK 1376339 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $432.6K 1 sales by 1 insiders
- Filings on record
- 142 since 2021-07-29, latest 2026-07-07 08:53
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Maersk-Moller Kimberly | Chief Commercial Off | — | $432.6K |
| Whitlow Ricci S | COO | — | — |
| Hulse William Frank IV | GC, CAO | — | — |
| DOUG RICE | CFO | — | — |
| Newton Todd | Dir | — | — |
| Capper Joseph H | CEO | — | — |
| Olson Tiffany | Dir | — | — |
| PUHY DOROTHY E | Dir | — | — |
| BIERMAN JAMES L | Dir | — | — |
| HAWKINS WILLIAM A | Dir | — | — |
Transactions 147
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-09 | 2023-03-07 | MDXG | Carlson Peter M | CFO | S - Sale | $4.24 | -12.1K | 534.1K | -2% | -$51.1K | |
| 2023-02-24 | 2023-02-23 | MDXG | Hulse William Frank IV | GC, CAO | S - Sale | $4.53 | -15.6K | 349.4K | -4% | -$70.5K | |
| 2023-02-24 | 2023-02-23 | MDXG | Carlson Peter M | CFO | S - Sale | $4.50 | -19.0K | 546.2K | -3% | -$85.5K | |
| 2022-12-27 | 2022-12-22 | MDXG | Carlson Peter M | CFO | S - Sale | $2.82 | -4,992 | 565.2K | -0.9% | -$14.1K | |
| 2022-09-19 | 2022-09-15 | MDXG | Newton Todd | Interim CEO, Dir | A - Grant | $0.00 | +200.0K | 325.6K | +159% | $0 | |
| M | 2022-09-14 | 2022-09-12+ | MDXG | Stein Robert Benjamin | Pres, Regenerative Med | S - Sale | $3.45 | -27.3K | 287.0K | -9% | -$94.2K |
| 2022-08-16 | 2022-08-12 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med | S - Sale | $4.04 | -8,503 | 306.0K | -3% | -$34.4K | |
| 2022-08-11 | 2022-08-09 | MDXG | Kashyap Rohit | Pres, WC, Surgical | S - Sale | $4.21 | -12.3K | 430.1K | -3% | -$52.0K | |
| 2022-08-08 | 2022-08-04 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med | S - Sale | $3.62 | -19.5K | 314.5K | -6% | -$70.6K | |
| 2022-06-30 | 2022-06-28 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med | S - Sale | $3.47 | -14.6K | 334.0K | -4% | -$50.7K | |
| 2022-06-13 | 2022-06-07 | MDXG | BEHRENS M KATHLEEN | Dir | A - Grant | $3.96 | +44.2K | 125.6K | +54% | +$175.0K | |
| 2022-06-13 | 2022-06-07 | MDXG | HAWKINS WILLIAM A | Dir | A - Grant | $3.96 | +44.2K | 116.9K | +61% | +$175.0K | |
| 2022-06-13 | 2022-06-07 | MDXG | Newton Todd | Dir | A - Grant | $3.96 | +44.2K | 125.6K | +54% | +$175.0K | |
| 2022-06-13 | 2022-06-07 | MDXG | LAURENCIN CATO T | Dir | A - Grant | $3.96 | +44.2K | 94.8K | +87% | +$175.0K | |
| 2022-06-13 | 2022-06-09 | MDXG | WRIGHT TIMOTHY R | CEO, Dir | S - Sale | $3.75 | -112.0K | 1.71M | -6% | -$420.0K | |
| 2022-06-13 | 2022-06-07 | MDXG | BIERMAN JAMES L | Dir | A - Grant | $3.96 | +44.2K | 125.6K | +54% | +$175.0K | |
| 2022-06-13 | 2022-06-07 | MDXG | GARDNER PHYLLIS | Dir | A - Grant | $3.96 | +44.2K | 81.7K | +118% | +$175.0K | |
| 2022-06-13 | 2022-06-10 | MDXG | Giuliani Michael J | Dir | A - Grant | $3.96 | +44.2K | 94.8K | +87% | +$175.0K | |
| 2022-05-10 | 2022-05-06 | MDXG | Phelan William Lawrence | CAO | S - Sale | $3.81 | -5,750 | 144.6K | -4% | -$21.9K | |
| 2022-05-10 | 2022-05-09 | MDXG | Graves Mark | SVP, CCO | S - Sale | $3.50 | -3,891 | 133.6K | -3% | -$13.6K | |
| 2022-05-04 | 2022-05-02 | MDXG | Turner Scott M | SVP, Ops, Procurement | S - Sale | $4.00 | -5,260 | 226.6K | -2% | -$21.0K | |
| 2022-04-12 | 2022-04-08 | MDXG | Graves Mark | SVP, CCO | A - Grant | $4.62 | +48.5K | 137.5K | +54% | +$224.0K | |
| 2022-04-12 | 2022-04-08 | MDXG | Hulse William Frank IV | GC, CAO | A - Grant | $4.62 | +178.6K | 364.9K | +96% | +$825.0K | |
| 2022-04-12 | 2022-04-08 | MDXG | Carlson Peter M | CFO | A - Grant | $4.62 | +187.5K | 570.2K | +49% | +$866.2K | |
| 2022-04-12 | 2022-04-08 | MDXG | Stein Robert Benjamin | Pres, Regenerative Med | A - Grant | $4.62 | +178.6K | 348.6K | +105% | +$825.0K | |
| 2022-04-12 | 2022-04-08 | MDXG | Phelan William Lawrence | CAO | A - Grant | $4.62 | +53.0K | 150.4K | +54% | +$245.0K | |
| 2022-04-12 | 2022-04-08 | MDXG | Kashyap Rohit | Pres, WC, Surgical | A - Grant | $4.62 | +178.6K | 442.4K | +68% | +$825.0K | |
| 2022-04-12 | 2022-04-08 | MDXG | WRIGHT TIMOTHY R | CEO, Dir | A - Grant | $4.62 | +602.7K | 1.82M | +49% | +$2.78M | |
| 2022-04-12 | 2022-04-08 | MDXG | Turner Scott M | SVP, Ops, Procurement | A - Grant | $4.62 | +61.5K | 231.9K | +36% | +$284.0K | |
| 2022-03-10 | 2022-03-08 | MDXG | Phelan William Lawrence | CAO | S - Sale | $4.86 | -3,268 | 97.4K | -3% | -$15.9K | |
| 2022-03-10 | 2022-03-08 | MDXG | Stein Robert Benjamin | EVP, Research, Development | S - Sale | $4.86 | -11.7K | 170.0K | -6% | -$56.7K | |
| 2022-03-10 | 2022-03-08 | MDXG | Hulse William Frank IV | GC | S - Sale | $4.86 | -9,990 | 186.3K | -5% | -$48.6K | |
| 2022-03-10 | 2022-03-08 | MDXG | Kashyap Rohit | EVP, Chief Commercial Off | S - Sale | $4.86 | -8,770 | 263.8K | -3% | -$42.6K | |
| 2022-03-10 | 2022-03-08 | MDXG | Graves Mark | SVP, CCO | S - Sale | $4.86 | -3,234 | 89.0K | -4% | -$15.7K | |
| 2022-03-10 | 2022-03-08 | MDXG | Carlson Peter M | CFO | S - Sale | $4.86 | -10.7K | 382.7K | -3% | -$52.2K | |
| 2022-03-10 | 2022-03-08 | MDXG | Turner Scott M | SVP, Ops, Procurement | S - Sale | $4.86 | -4,155 | 170.4K | -2% | -$20.2K | |
| 2022-03-10 | 2022-03-08 | MDXG | WRIGHT TIMOTHY R | CEO, Dir | S - Sale | $4.86 | -45.6K | 1.22M | -4% | -$221.7K | |
| 2022-03-10 | 2020-07-06 | MDXG | Phelan William Lawrence | CAO | A - Grant | $5.40 | +8,474 | 100.6K | +9% | +$45.8K | |
| 2022-03-01 | 2022-02-25 | MDXG | Carlson Peter M | CFO | S - Sale | $4.83 | -17.4K | 393.4K | -4% | -$84.0K | |
| 2022-02-28 | 2022-02-24 | MDXG | Graves Mark | SVP, CCO | S - Sale | $4.32 | -4,525 | 92.2K | -5% | -$19.5K | |
| 2022-02-25 | 2022-02-23 | MDXG | Hulse William Frank IV | GC | S - Sale | $4.41 | -13.5K | 196.3K | -6% | -$59.5K | |
| 2022-02-25 | 2022-02-23 | MDXG | Turner Scott M | SVP, Ops, Procurement | S - Sale | $4.50 | -5,738 | 174.6K | -3% | -$25.8K | |
| 2022-02-25 | 2022-02-23 | MDXG | WRIGHT TIMOTHY R | CEO, Dir | S - Sale | $4.31 | -61.0K | 1.27M | -5% | -$262.9K | |
| 2021-08-17 | 2021-08-16 | MDXG | Stein Robert Benjamin | EVP, Research, Development | S - Sale | $11.85 | -9,362 | 181.7K | -5% | -$110.9K | |
| 2021-07-30 | 2021-07-28 | MDXG | Carlson Peter M | CFO | A - Grant | $0.00 | +35.2K | 424.1K | +9% | $0 | |
| 2021-07-30 | 2021-07-28 | MDXG | Carlson Peter M | CFO | F - Tax | $12.26 | -13.3K | 410.8K | -3% | -$162.7K | |
| 2021-07-29 | 2021-07-27 | MDXG | Graves Mark | SVP, CCO | F - Tax | $12.07 | -1,505 | 98.3K | -2% | -$18.2K |
Purchase Sale Sale after option exercise All abbreviations